Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study

Authors: Vangenechten, Inge, Smejkal, Petr, Zapletal, Ondrej, Michiels, Jan Jacques, Berneman, Zwi, Zavrelova, Jiri, Blatný, Jan, Penka, Miroslav, Gadisseur, Alain

Source: Thrombosis and haemostasis. 119(4):594-605

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186438729.0x000001&indx=1&recIds=ETOCvdc_100186438729.0x000001

Aspirin responsive erythromelalgia in JAK2-thrombocythemia and incurable inherited erythrothermalgia in neuropathic Nav1.7 sodium channelopathy: from Mitchell 1878 to Michiels 2017

Authors: Michiels, Jan Jacques

Source: Expert opinion on orphan drugs. 5(2):111-129

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103161077.0x000001&indx=1&recIds=ETOCvdc_100103161077.0x000001

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test

Authors: Michiels, Jan Jacques, Smejkal, Petr, Penka, Miroslav, Batorova, Angelika, Pricangova, Tatiana, Budde, Ulrich, Vangenechten, Inge, Gadisseur, Alain

Source: Clinical and applied thrombosis/hemostasis. 23(6):518-531

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN612681271&indx=1&recIds=ETOCRN612681271

Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo

Authors: Geisen, Ulrich, Zieger, Barbara, Nakamura, Lea, Weis, Andreas, Heinz, Jürgen, Michiels, Jan Jacques, Heilmann, Claudia

Source: In Thrombosis Research August 2014 134(2):246-250

Safe Exclusion of Deep Vein Thrombosis by a Rapid Sensitive ELISA D-dimer and Compression Ultrasonography in 1330 Outpatients With Suspected DVT

Authors: Michiels, Jan Jacques, Maasland, Hanny, Moossdorff, Wim, Lao, Mildred, Godiseur, Alain, Schroyens, Wilfried

Source: Angiology. 67(8):781-787

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN607530232&indx=1&recIds=ETOCRN607530232

A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE

Authors: Schneppenheim, Reinhard ^*, Michiels, Jan Jacques, Obser, Tobias, Oyen, Florian, Pieconka, Antje, Schneppenheim, Sonja, Will, Kerstin, Zieger, Barbara, Budde, Ulrich

Source: In Blood 10 June 2010 115(23):4894-4901

Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin

Authors: Michiels, Jan Jacques, Berneman, Zwi, Schroyens, Wilfried, Koudstaal, Peter J., Lindemans, Jan, van Vliet, Huub H.D.M.

Source: In Blood Cells, Molecules and Diseases 2006 36(2):199-205

Analysis of von Willebrand Disease in the “Heart of Europe”

Authors: Vangenechten, Inge, Smejkal, Petr, Zavrelova, Jiri, Zapletal, Ondrej, Wild, Alexander, Michiels, Jan Jacques, Berneman, Zwi, Blatny, Jan, Batorova, Angelika, Prigancova, Tatiana, Penka, Miroslav, Gadisseur, Alain

Source: TH Open; October 2022, Vol. 6 Issue: 4 pe335-e346, 12p

2016 WHO Clinical Molecular and Pathological Criteria for Classification and Staging of Myeloproliferative Neoplasms (MPN) Caused by MPN Driver Mutations in the JAK2, MPL and CALR Genes in the Context of New 2016 WHO Classification: Prognostic and Therapeutic Implications.

Authors: MICHIELS, Jan Jacques^1,2, TEVET, Mihaela² cgmicky@yahoo.com, TRIFA, Adrian^3,4, NICULESCU-MIZIL, Emilia⁵, LUPU, Anca⁶, VLADAREANU, Ana-Maria⁷, BUMBEA, Horia⁷, ILEA, Anca⁸, DOBREA, Camelia⁹, GEORGESCU, Daniela², PATRINOIU, Oana², POPESCU, Mihaela², MURAT, Meilin², DRAGAN, Cornel², MIHAI, Felicia², ZURAC, Sabina¹⁰, ANGELESCU, Silvana⁶, IOVA, Anamaria¹¹, POPA, Alina¹¹, GOGULESCU, Rodica¹¹

Source: Maedica - a Journal of Clinical Medicine. 2016, Vol. 11 Issue 1, p5-25. 21p.

Subject Terms: *TYPE 2 diabetes, *BODY composition, *GLYCEMIC control, *TRIGLYCERIDES, *LIPIDS

The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2^V617F Mutation.

Alternate Title: JAK2V617F Mutasyonu Bulunan Prefibrotik Myeloproliferatif Neoplazmların Tanı, Sınıflandırma ve Evrelendirmesinde Dünya Sağlık Örgütü Kriterlerinin 2007/2008 Gözden Geçirilmesi ve Avrupa Klinik, Moleküler ve Patolojik (ECMP) Kriterleri.

Authors: Michiels, Jan Jacques^1,2 goodheartcenter@upcmail.nl, Kate, Fibo Ten³, Lam, King H.³, Schroyens, Wilfried¹, Berneman, Zwi¹, De Raeve, Hendrik⁴

Source: Turkish Journal of Hematology. 2014, Vol. 31 Issue 3, p239-254. 16p.

Subject Terms: *ERYTHROCYTES, *BLOOD volume, *CYTOCHEMISTRY, *DIAGNOSIS, *ERYTHROPOIESIS, *LONGITUDINAL method, *GENETIC mutation, *MYELOFIBROSIS, *MYELOPROLIFERATIVE neoplasms, *POLYCYTHEMIA, *THROMBOCYTOSIS, *TUMOR classification, BONE marrow examination

Company/Entity: WORLD Health Organization

Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management

Authors: Michiels, Jan Jacques, Budde, Ulrich, van der Planken, Marc, van Vliet, Huub H.D.M., Schroyens, Wilfried, Berneman, Zwi

Source: In Best Practice & Research Clinical Haematology June 2001 14(2):401-436

Physiopathology, Etiologic Factors, Diagnosis, and Course of Polycythemia Vera as Related to Therapy According to William Dameshek, 1940-1950.

Alternate Title: William Dameshek'e (1940-1950) Göre Tedavi Açısından Polistemia Vera'nın Fizyopatolojisi, Etiyolojik Faktörleri, Tanısı ve Seyri.

Authors: Michiels, Jan Jacques¹ goodheartcenter@upcmail.nl

Source: Turkish Journal of Hematology. Jun2013, Vol. 30 Issue 2, p102-110. 9p.

Subject Terms: *POLYCYTHEMIA treatment, *BLOOD cell count, *BONE marrow, *GENETIC mutation, *PHYSICIANS, *SYMPTOMS, *POLYCYTHEMIA, *GENETICS, *DIAGNOSIS

Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: A distinct aspirin-responsive and coumadin-resistant arterial thrombophilia

Authors: Michiels, Jan Jacques^1,2 (AUTHOR) jan.michiels@uza.be, Berneman, Zwi¹ (AUTHOR), Schroyens, Wilfried¹ (AUTHOR), Koudstaal, Peter J.³ (AUTHOR), Lindemans, Jan⁴ (AUTHOR), Neumann, H. A. Martino⁵ (AUTHOR), van Vliet, Huub H. D. M.⁶ (AUTHOR)

Source: Platelets. Dec2006, Vol. 17 Issue 8, p528-544. 17p. 1 Color Photograph, 5 Charts, 9 Graphs.

Subject Terms: *MICROCIRCULATION disorders, *CEREBRAL ischemia, *ERYTHROMELALGIA, *CORONARY disease, *THROMBOCYTOSIS, *POLYCYTHEMIA vera

Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond.

Authors: Michiels, Jan Jacques^1,2

Source: Hematology. Sep2005 Supplement 1, Vol. 10, p215-223. 9p. 4 Charts.

Subject Terms: *MYELOPROLIFERATIVE neoplasms, *BONE marrow diseases, *HISTOPATHOLOGY, *BIOMARKERS, *DIAGNOSIS, *MYELOFIBROSIS, *PROGNOSIS, *MYELOID metaplasia

Review.

Authors: Michiels, Jan Jacques¹ Postbus@goodheartcenter.demon.nl, Berneman, Zwi N.¹, Schroyens, Wilfried¹, Vliet, Huub H. D. M. Van²

Source: Platelets. Mar2004, Vol. 15 Issue 2, p67-84. 18p.

Subject Terms: *MICROCIRCULATION disorders, *ERYTHROMELALGIA, *VENOUS thrombosis, *THROMBOCYTOPENIA, *HEMORRHAGE, *BLOOD diseases

Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.

Authors: Michiels, Jan Jacques^1,2 postbus@goodheartcenter.demon.nl

Source: Hematology Journal. 2004, Vol. 5 Issue 2, p93-102. 10p.

Subject Terms: *BONE marrow, *HISTOPATHOLOGY, *BIOMARKERS, *THROMBOCYTOSIS, *POLYCYTHEMIA vera, *MYELOID metaplasia

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders

Authors: Michiels, Jan Jacques, De Raeve, Hendrik, Hebeda, Konnie, Lam, King H., Berneman, Zwi, Schroyens, Wilfried, Schwarz, Jiri

Source: In Leukemia Research 2007 31(8):1031-1038